Stannous Chloride in the Preparation of 99mTc Pharmaceuticals

[1]  A. Maitra,et al.  Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles. , 2005, International journal of pharmaceutics.

[2]  P. Blower,et al.  Direct labelling via simultaneous reduction of pertechnetate and a disulfide bond. , 2002 .

[3]  K. Schwochau.  Technetium: Chemistry and Radiopharmaceutical Applications , 2000 .

[4]  I. Zolle,et al.  Stannous Ion Determination: Importance and Relevance for Radiopharmaceutical Kits , 1997 .

[5]  L. Thunus,et al.  Polarographic determination of Sn(II) in samples containing Sn(IV) such as in 99m-Technetium radiopharmaceutical kits , 1996 .

[6]  J. Vanderheyden,et al.  Synthesis and characterization of cationic technetium complexes of 1,2-bis(dimethylphosphino)ethane (DMPE). Structure determinations of trans-[TcV(DMPE)2(OH)(O)](F3CSO3)2, trans-[TcIII(DMPE)2Cl2]F3CSO3, and [TcI(DMPE)3]+ using x-ray diffraction, EXAFS, and technetium-99 NMR [Erratum to document cite , 1990 .

[7]  Charles B. Sampson,et al.  Textbook of radiopharmacy : theory and practice , 1990 .

[8]  D. Gambino,et al.  Solid phase reduction of 99mTcO 4− with zinc : A method for the preparation of difficult 99m complexes , 1989 .

[9]  Michael J. Clarke,et al.  Medical Diagnostic Imaging with Complexes of 99mTc , 1987 .

[10]  S. Vilcek,et al.  99mTc-labelled compounds prepared with tungsten(III) as the reducing agent , 1985 .

[11]  S. Vilcek,et al.  99mTc-labelled compounds prepared with molybdenum III as reducing agent. , 1984, The International journal of applied radiation and isotopes.

[12]  S. Vilcek,et al.  Tc-Labelled Compounds Prepared with Ti(III) as Reducing Agent , 1982 .

[13]  V. J. Sodd,et al.  Cationic Tc-99m complexes as potential myocardial imaging agents. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M. Francis,et al.  Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Rudy W. Thomas,et al.  Technetium radiopharmaceutical development. 1. Synthesis, characterization, and structure of dichloro[hydrotris(1-pyrazolyl)borato]oxotechnetium(V) , 1979 .

[16]  K. Unverferth,et al.  Die Reaktion von Pertechnetat mit Cystein , 1978 .

[17]  F. Cotton,et al.  A thiol complex of technetium pertinent to radiopharmaceutical use of technetium-99m , 1978 .

[18]  O. Noronha.  Time-Dependent Characteristics of Sn-Complexes for Preparing 99mTc-Labelled Radiopharmaceuticals and their Bioavailabilities - a Review , 1978, Nuklearmedizin.

[19]  G. Meinken,et al.  Problems associated with stannous 99mTc-radiopharmaceuticals. , 1977, The International journal of applied radiation and isotopes.

[20]  E. Deutsch,et al.  Structural characterization of a bridged 99Tc-Sn-dimethylglyoxime complex: implications for the chemistry of 99mTc-radiopharmaceuticals prepared by the Sn (II) reduction of pertechnetate. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. C. Gil,et al.  Electrolytical labeling of 99mTc radiopharmaceuticals. , 1976, The International journal of applied radiation and isotopes.

[22]  G. Meinken,et al.  The reduction of pertechnetate-99 by stannous chloride—I. The stoichiometry of the reaction in HCl, in a citrate buffer and in a DTPA buffer , 1975 .

[23]  J. Alvarez.  Radiopharmaceuticals prepared with stannous chloride , 1975 .

[24]  A. Yokoyama,et al.  The role of ascorbic acid with the ferric ion in labelling human serum albumin with 99mTc , 1975 .

[25]  P. Richards,et al.  Chemistry of technetium 99m. , 1974, Seminars in nuclear medicine.

[26]  W. Eckelman,et al.  The chemistry of technetium labeling of radiopharmaceuticals by electrolysis. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  L. Oniciu,et al.  Contribution to the study of the mechanism of labelling human serum albumin (HSA) with technetium-99m. , 1973, The International journal of applied radiation and isotopes.

[28]  W. Eckelman,et al.  Analytical Pitfalls with 99mTc-labeled Compounds , 1972 .

[29]  W. C. Eckelman,et al.  99m Tc-human serum albumin. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  W. Eckelman,et al.  Chemical state of 99mTc in biomedical products. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  H. Dworkin,et al.  Rapid closed-system production of 99m Tc-albumin using electrolysis. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  H. S. Winchell,et al.  Use of Fe(II) or Sn(II) alone for technetium labeling of albumin. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  W. Eckelman,et al.  Instant 99mTc-DTPA. , 1970, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  H. Friedell,et al.  Electrolytic complexation of 99mTc at constant current: its applications in nuclear medicine. , 1970, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  K. Lidén,et al.  99m Tc-labelled human serum albumin: a study of the labelling procedure. , 1969, The International journal of applied radiation and isotopes.

[36]  P. P. Benjamin.  A rapid and efficient method of preparing 99mTc-human serum albumin: its clinical applications. , 1969, The International journal of applied radiation and isotopes.

[37]  H. Stern,et al.  PREPARATION OF TECHNETIUM (TC99M)-LABELED SERUM ALBUMIN (HUMAN). , 1965, The International journal of applied radiation and isotopes.

[38]  J. Donaldson,et al.  789. Pure tin(II) sulphate , 1960 .

[39]  H. Fischer.  Colloidal stannic oxide; animal studies on a new hepatolienographic agent. , 1957, Radiology.